| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |